© Thibault Rouxel, Marie-Eve Val
Colonie de Vibrio cholerae. En bleu, les bactéries dont les chromosomes ont été fusionnés.

Molecular Prevention and Therapy of Human Diseases


Vaccination is one of the most successful tools for controlling infectious diseases. Although it is generally perceived as the “golden solution” , it has recently been shown that the extensive use of vaccines may lead to undesirable effects (e.g. poliomyelitis epidemics due to vaccine-derived viruses) or the resurgence of a disease and its clinical characteristics as well as the development of new biological diagnosis (e.g. re-emergence of whooping cough after 40 years of vaccination). In the documented cases, epidemiological studies clearly indicate that extensive vaccinations can induce modifications of the pathogens over time, the emergence of new pathogens due to changes in the ecosystems, or change in the transmission of the disease. Therefore, to optimise the benefits of immunization programs and prevent new global adverse effects of vaccines (and the subsequent detrimental impact in the general public), the consequences of extensive vaccinations on the pathogen, ecosystem and/or human host populations remain to be evaluated.

In this context, the main objective of this unit is to evaluate the consequences of extensive vaccination in human populations, and to propose adapted strategies of prevention for children and adults and new therapeutic tools in order to face some of these consequences.

Our unit is also National Centre of Reference of pertussis and other Bordetelloses and National Centre of Reference of diphtheriae complex.

Our projects :


To listen more about our research activities, you can access :

  • Video of Nicole Guiso, former Head of Unit




Secretariat: + 33 (0) 1 45 68 83 34
Email: isabelle.moulherat@pasteur.fr

Head of the Unit, Dr Benoit Garin

25-28 Rue du Docteur Roux
75015, Paris